<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04428541</url>
  </required_header>
  <id_info>
    <org_study_id>PDU_2020_1</org_study_id>
    <nct_id>NCT04428541</nct_id>
  </id_info>
  <brief_title>Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies</brief_title>
  <acronym>EVEIL</acronym>
  <official_title>Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In some symmetrical pediatric ocular pathologies, the treatment is surgical with usually
      satisfactory postoperative results in visual terms.

      However, it is often difficult to choose the right moment to operate. The main difficulty is
      that the child's vision is unknown since the child is still in a preverbal age.

      The investigators have developed a questionnaire with the aim of quantifying the child's
      vision so that the decision is most justified. The items of this questionnaire were
      established based on the literature and were submitted to a panel of experts in
      ophthalmo-pediatrics. The objective of this study is to determine the internal validity and
      as far as possible (since there is no equivalent tool) the external validity of the
      questionnaire developed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure the internal validity of the questionnaire developed to assess the visual acuity of preverbal children</measure>
    <time_frame>Inclusion</time_frame>
    <description>Reliability evaluated by Cronbach's alpha coefficient and its 95% confidence interval.
unabbreviated scale title : Assessment of Visual Function in Preverbal Children in Bilateral Ocular Pathology
Minimum value : 0
Maximum value : 18
Higher scores mean better outcome</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Eye Diseases</condition>
  <condition>Vision Disorders</condition>
  <arm_group>
    <arm_group_label>Questionnaire</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Description : 18 items questionnaire, filled by the parents of the child</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire for visual function assessment of preverbal children</intervention_name>
    <description>18 items questionnaire</description>
    <arm_group_label>Questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Common to the three groups:

          -  Patient aged 0 to 36 months

          -  Diagnosis of known ocular pathology

        For patients targeted by the questionnaire:

        - Patient with operable bilateral ocular pathology

        For negative controls:

        - Patient without ocular pathology inducing a decrease in vision

        For positive controls:

          -  Patient with inoperable bilateral ocular pathology

          -  Patient without light perception

        Exclusion Criteria:

          -  Patient with unilateral ocular pathology

          -  Verbal patients (able to express themselves through speech)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>36 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal DUREAU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Am√©lie YAVCHITZ, MD</last_name>
    <phone>(0)148036454</phone>
    <phone_ext>+33</phone_ext>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pascal DUREAU, MD</last_name>
    <email>pdureau@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal DUREAU, MD</last_name>
      <email>pdureau@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eye Diseases</keyword>
  <keyword>Vision Disorders</keyword>
  <keyword>Questionnaire Design</keyword>
  <keyword>Children</keyword>
  <keyword>Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

